Publikationen von W Birchmeier

Behrens, J.; Mareel, M.; Van Roy, F.; Birchmeier, W.: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. The Journal of Cell Biology: JCB 108 (6), S. 2435 - 2447 (1989)

Hamel, E.; Katoh, F.; Mueller, G.; Birchmeier, W.; Yamasaki, H.: Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation. Cancer Research 48 (10), S. 2832 - 2836 (1988)

Müller, G.; Behrens, J.; Nussbaumer, U.; Böhlen, P.; Birchmeier, W.: Inhibitory action of transforming growth factor beta on endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 84 (16), S. 5600 - 5604 (1987)

Wieland, I.; Müller, G.; Braun, S.; Birchmeier, W.: Reversion of the transformed phenotype of B16 mouse melanoma: involvement of an 83 kd cell surface glycoprotein in specific growth inhibition. Cell 47 (5), S. 675 - 685 (1986)

Fràter-Schröder, M.; Müller, G.; Birchmeier, W.; Böhlen, P.: [Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells]. Schweizerische Medizinische Wochenschrift 116 (34), S. 1160 - 1162 (1986)

Fràter-Schröder, M.; Müller, G.; Birchmeier, W.; Böhlen, P.: Transforming growth factor-beta inhibits endothelial cell proliferation. Biochemical and Biophysical Research Communications 137 (1), S. 295 - 302 (1986)

Behrens, J.; Birchmeier, W.; Goodman, S.; Imhof, B.: Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. Methods in Cell Biology 101 (4), S. 1307 - 1315 (1985)

Goodman, S.; Vollmers, H.; Birchmeier, W.: Control of cell locomotion: perturbation with an antibody directed against specific. Cell 41 (3), S. 1029 - 1038 (1985)

Vollmers, H.; Imhof, B.; Wieland, I.; Hiesel, A.; Birchmeier, W.: Monoclonal antibodies NORM-1 and NORM-2 induce more normal behavior of tumor cells in vitro and reduce tumor growth in vivo. Cell 40 (3), S. 547 - 557 (1985)

Vollmers, H.; Imhof, B.; Braun, S.; Waller, C.; Schirrmacher, V.; Birchmeier, W.: Monoclonal antibodies which prevent experimental lung metastases: Interference with the adhesion of tumour cells to laminin. FEBS Letters 172 (1), S. 17 - 20 (1984)

Imhof, B.; Vollmers, H.; Goodman, S.; Birchmeier, W.: Cell-cell interaction and polarity of epithelial cells: specific perturbation using a monoclonal antibody. Cell 35 (3 Part 2), S. 667 - 675 (1983)

Vollmers, H.; Birchmeier, W.: Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells. Proceedings of the National Academy of Sciences of the United States of America 80 (22), S. 6863 - 6867 (1983)

Vollmers, H.; Birchmeier, W.: Monoclonal antibodies inhibit the adhesion of mouse B 16 melanoma cells in vitro and block lung metastasis in vivo. Proceedings of the National Academy of Sciences of the United States of America 80 (12), S. 3729 - 3733 (1983)

Imhof, B.; Marti, U.; Boller, K.; Frank, H.; Birchmeier, W.: Association between coated vesicles and microtubules. Experimental Cell Research 145 (1), S. 199 - 207 (1983)

Oesch, B.; Birchmeier, W.: New surface component of fibroblast's focal contacts identified by a monoclonal antibody. Cell 31 (3 Part 2), S. 671 - 679 (1982)